Display options
Cite
Surma MA, Herzog R, Vasilj A, et al. An automated shotgun lipidomics platform for high throughput, comprehensive, and quantitative analysis of blood plasma intact lipids. Eur J Lipid Sci Technol. 2015;117(10):1540-1549doi: 10.1002/ejlt.201500145.
Surma, M. A., Herzog, R., Vasilj, A., Klose, C., Christinat, N., Morin-Rivron, D., Simons, K., Masoodi, M., & Sampaio, J. L. (2015). An automated shotgun lipidomics platform for high throughput, comprehensive, and quantitative analysis of blood plasma intact lipids. European journal of lipid science and technology : EJLST, 117(10), 1540-1549. https://doi.org/10.1002/ejlt.201500145
Surma, Michal A, et al. "An automated shotgun lipidomics platform for high throughput, comprehensive, and quantitative analysis of blood plasma intact lipids." European journal of lipid science and technology : EJLST vol. 117,10 (2015): 1540-1549. doi: https://doi.org/10.1002/ejlt.201500145
Surma MA, Herzog R, Vasilj A, Klose C, Christinat N, Morin-Rivron D, Simons K, Masoodi M, Sampaio JL. An automated shotgun lipidomics platform for high throughput, comprehensive, and quantitative analysis of blood plasma intact lipids. Eur J Lipid Sci Technol. 2015 Oct;117(10):1540-1549. doi: 10.1002/ejlt.201500145. Epub 2015 Jul 20. PMID: 26494980; PMCID: PMC4606567.
Copy Download .nbib Format: NLM
Share it on

Eur J Lipid Sci Technol. 2015 Oct;117(10):1540-1549. doi: 10.1002/ejlt.201500145. Epub 2015 Jul 20.

An automated shotgun lipidomics platform for high throughput, comprehensive, and quantitative analysis of blood plasma intact lipids.

European journal of lipid science and technology : EJLST

Michal A Surma, Ronny Herzog, Andrej Vasilj, Christian Klose, Nicolas Christinat, Delphine Morin-Rivron, Kai Simons, Mojgan Masoodi, Julio L Sampaio

Affiliations

  1. Lipotype GmbH Dresden, Germany.
  2. Nestlé Institute of Health Sciences S.A. Lausanne, Switzerland.

PMID: 26494980 PMCID: PMC4606567 DOI: 10.1002/ejlt.201500145

Abstract

Blood plasma has gained protagonism in lipidomics studies due to its availability, uncomplicated collection and preparation, and informative readout of physiological status. At the same time, it is also technically challenging to analyze due to its complex lipid composition affected by many factors, which can hamper the throughput and/or lipidomics coverage. To tackle these issues, we developed a comprehensive, high throughput, and quantitative mass spectrometry-based shotgun lipidomics platform for blood plasma lipid analyses. The main hallmarks of this technology are (i) it is comprehensive, covering 22 quantifiable different lipid classes encompassing more than 200 lipid species; (ii) it is amenable to high-throughput, with less than 5 min acquisition time allowing the complete analysis of 200 plasma samples per day; (iii) it achieves absolute quantification, by inclusion of internal standards for every lipid class measured; (iv) it is highly reproducible, achieving an average coefficient of variation of <10% (intra-day), approx. 10% (inter-day), and approx. 15% (inter-site) for most lipid species; (v) it is easily transferable allowing the direct comparison of data acquired in different sites. Moreover, we thoroughly assessed the influence of blood stabilization with different anticoagulants and freeze-thaw cycles to exclude artifacts generated by sample preparation.

Keywords: Blood plasma; Clinical biomarker; High throughput; Lipids; Shotgun lipidomics

References

  1. PLoS One. 2014 Mar 14;9(3):e91806 - PubMed
  2. Metabolites. 2011 Dec 1;1(1):21-40 - PubMed
  3. Mol Biosyst. 2014 Jun;10(6):1364-76 - PubMed
  4. Anal Chem. 2011 Feb 1;83(3):940-9 - PubMed
  5. Anal Chem. 2007 Jun 1;79(11):4083-93 - PubMed
  6. Atherosclerosis. 2013 Jul;229(1):86-93 - PubMed
  7. Cell Preserv Technol. 2008 Sep 1;6(3):223-230 - PubMed
  8. Anal Chem. 2006 Sep 1;78(17):6202-14 - PubMed
  9. Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2723-32 - PubMed
  10. Circulation. 2014 May 6;129(18):1821-31 - PubMed
  11. J Lipid Res. 1964 Apr;5:225-31 - PubMed
  12. Expert Opin Drug Discov. 2012 Jan;7(1):63-72 - PubMed
  13. J Lipid Res. 2008 May;49(5):1137-46 - PubMed
  14. Lancet Diabetes Endocrinol. 2014 Oct;2(10):810-8 - PubMed
  15. Eur J Hum Genet. 2013 Jan;21(1):95-101 - PubMed
  16. Proteomics. 2005 Aug;5(13):3414-22 - PubMed
  17. Anal Chem. 2013 Feb 5;85(3):1852-9 - PubMed
  18. J Lipid Res. 2010 Nov;51(11):3299-305 - PubMed
  19. J Chromatogr A. 2013 Aug 2;1301:237-42 - PubMed
  20. Nat Rev Drug Discov. 2005 Jul;4(7):594-610 - PubMed
  21. Curr Opin Biotechnol. 2015 Feb;31:73-8 - PubMed
  22. Atherosclerosis. 2012 Jan;220(1):22-33 - PubMed
  23. Mass Spectrom Rev. 2012 Jan-Feb;31(1):134-78 - PubMed
  24. J Lipid Res. 2010 Oct;51(10):3074-87 - PubMed
  25. Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1582-4 - PubMed
  26. Ann Nutr Metab. 2013;62(2):98-112 - PubMed
  27. Anal Chem. 2013 Dec 17;85(24):12085-92 - PubMed
  28. J Lipid Res. 2001 Apr;42(4):663-72 - PubMed
  29. Genome Biol. 2011;12(1):R8 - PubMed
  30. Can J Biochem Physiol. 1959 Aug;37(8):911-7 - PubMed
  31. N Engl J Med. 2011 Nov 10;365(19):1812-23 - PubMed
  32. Anal Chem. 2002 Mar 1;74(5):941-9 - PubMed
  33. Rapid Commun Mass Spectrom. 2009 Sep;23(17):2711-23 - PubMed
  34. Mol Nutr Food Res. 2013 Aug;57(8):1306-18 - PubMed
  35. J Biol Chem. 1957 May;226(1):497-509 - PubMed
  36. J Lipid Res. 2010 Sep;51(9):2826-32 - PubMed
  37. J Chromatogr A. 2010 Jun 18;1217(25):4087-99 - PubMed
  38. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Aug 15;871(2):243-52 - PubMed
  39. PLoS One. 2012;7(1):e29851 - PubMed
  40. PLoS One. 2012;7(11):e48889 - PubMed
  41. Anal Chem. 2013 Sep 17;85(18):8757-63 - PubMed
  42. J Mass Spectrom. 2012 Jan;47(1):96-104 - PubMed

Publication Types